Market revenue in 2023 | USD 57.4 million |
Market revenue in 2030 | USD 88.5 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Cell based |
Fastest growing segment | Non-Cell Based |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cell Based, Non-Cell Based |
Key market players worldwide | B. Braun, Zimmer Biomet Holdings Inc, Stryker Corp, Becton Dickinson & Co, Anika Therapeutics Inc, Smith & Nephew PLC, Vericel Corp, Johnson & Johnson, Medacta Group SA Ordinary Shares, Collagen Solutions, Arthrex |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cartilage repair market will help companies and investors design strategic landscapes.
Cell based was the largest segment with a revenue share of 79.79% in 2023. Horizon Databook has segmented the South Korea cartilage repair market based on cell based, non-cell based covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea cartilage repair market , including forecasts for subscribers. This country databook contains high-level insights into South Korea cartilage repair market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account